08Jul
BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer
BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commissioning and funding of six molecular diagnostic tests for cancer in the NHS in England for 2016/17.
It aims to provide NHS staff – be they commissioner or hospital provider financial staff, clinicians and pathology staff – with a clear understanding how the new funding arrangements for these tests in 2016/17 will operate to support timely and appropriate patient access.
To read the full briefing, click here. For more information, contact BIVDA Chief Executive, Doris-Ann Williams.
Related
Please find below a statement from BIVDA Chief Executive Doris-Ann Williams regarding the new plans ...
Read More >
A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...
Read More >
Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE sa...
Read More >
The British In Vitro Diagnostics Association (BIVDA) has today unveiled its new website including a ...
Read More >
NHSEI SBRI Healthcare grant for Psyros’ rapid, ultra-sensitive test for heart attack marker&nb...
Read More >
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer lead...
Read More >